ORGO
Price
$4.44
Change
+$0.11 (+2.54%)
Updated
Apr 23, 04:59 PM (EDT)
Capitalization
374.78M
14 days until earnings call
PRGO
Price
$24.73
Change
-$0.08 (-0.32%)
Updated
Apr 23, 04:59 PM (EDT)
Capitalization
4.35B
19 days until earnings call
Ad is loading...

ORGO vs PRGO

Header iconORGO vs PRGO Comparison
Open Charts ORGO vs PRGOBanner chart's image
Organogenesis Holdings
Price$4.44
Change+$0.11 (+2.54%)
Volume$29.4K
Capitalization374.78M
Perrigo
Price$24.73
Change-$0.08 (-0.32%)
Volume$10.89K
Capitalization4.35B
ORGO vs PRGO Comparison Chart
Loading...
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ORGO vs. PRGO commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORGO is a Buy and PRGO is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (ORGO: $4.44 vs. PRGO: $24.74)
Brand notoriety: ORGO and PRGO are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ORGO: 53% vs. PRGO: 85%
Market capitalization -- ORGO: $374.78M vs. PRGO: $4.35B
ORGO [@Pharmaceuticals: Other] is valued at $374.78M. PRGO’s [@Pharmaceuticals: Other] market capitalization is $4.35B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORGO’s FA Score shows that 1 FA rating(s) are green whilePRGO’s FA Score has 1 green FA rating(s).

  • ORGO’s FA Score: 1 green, 4 red.
  • PRGO’s FA Score: 1 green, 4 red.
According to our system of comparison, ORGO is a better buy in the long-term than PRGO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORGO’s TA Score shows that 6 TA indicator(s) are bullish while PRGO’s TA Score has 6 bullish TA indicator(s).

  • ORGO’s TA Score: 6 bullish, 4 bearish.
  • PRGO’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ORGO is a better buy in the short-term than PRGO.

Price Growth

ORGO (@Pharmaceuticals: Other) experienced а +4.47% price change this week, while PRGO (@Pharmaceuticals: Other) price change was -1.59% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.96%. For the same industry, the average monthly price growth was -6.07%, and the average quarterly price growth was -9.98%.

Reported Earning Dates

ORGO is expected to report earnings on Aug 06, 2025.

PRGO is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.96% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRGO($4.35B) has a higher market cap than ORGO($375M). PRGO has higher P/E ratio than ORGO: PRGO (341.25) vs ORGO (70.25). ORGO YTD gains are higher at: 35.312 vs. PRGO (-2.515). PRGO has higher annual earnings (EBITDA): 525M vs. ORGO (36M). PRGO has more cash in the bank: 751M vs. ORGO (104M). ORGO has less debt than PRGO: ORGO (119M) vs PRGO (4.07B). PRGO has higher revenues than ORGO: PRGO (4.66B) vs ORGO (433M).
ORGOPRGOORGO / PRGO
Capitalization375M4.35B9%
EBITDA36M525M7%
Gain YTD35.312-2.515-1,404%
P/E Ratio70.25341.2521%
Revenue433M4.66B9%
Total Cash104M751M14%
Total Debt119M4.07B3%
FUNDAMENTALS RATINGS
ORGO vs PRGO: Fundamental Ratings
ORGO
PRGO
OUTLOOK RATING
1..100
758
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
62
Fair valued
PROFIT vs RISK RATING
1..100
93100
SMR RATING
1..100
9091
PRICE GROWTH RATING
1..100
4159
P/E GROWTH RATING
1..100
82
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRGO's Valuation (62) in the Pharmaceuticals Other industry is in the same range as ORGO (74) in the Financial Conglomerates industry. This means that PRGO’s stock grew similarly to ORGO’s over the last 12 months.

ORGO's Profit vs Risk Rating (93) in the Financial Conglomerates industry is in the same range as PRGO (100) in the Pharmaceuticals Other industry. This means that ORGO’s stock grew similarly to PRGO’s over the last 12 months.

ORGO's SMR Rating (90) in the Financial Conglomerates industry is in the same range as PRGO (91) in the Pharmaceuticals Other industry. This means that ORGO’s stock grew similarly to PRGO’s over the last 12 months.

ORGO's Price Growth Rating (41) in the Financial Conglomerates industry is in the same range as PRGO (59) in the Pharmaceuticals Other industry. This means that ORGO’s stock grew similarly to PRGO’s over the last 12 months.

PRGO's P/E Growth Rating (2) in the Pharmaceuticals Other industry is in the same range as ORGO (8) in the Financial Conglomerates industry. This means that PRGO’s stock grew similarly to ORGO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ORGOPRGO
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
69%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
67%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 7 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
65%
Advances
ODDS (%)
Bullish Trend 10 days ago
78%
Bullish Trend 7 days ago
62%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 16 days ago
66%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
60%
View a ticker or compare two or three
Ad is loading...
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TSLR11.761.00
+9.29%
GraniteShares 2x Long TSLA Daily ETF
GXC80.752.18
+2.77%
SPDR® S&P China ETF
IXC37.480.83
+2.26%
iShares Global Energy ETF
JULZ38.650.60
+1.59%
Trueshares Structured Outcome July ETF
XYLE25.61N/A
N/A
Global X S&P 500 ESG Covered Call ETF

ORGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORGO has been loosely correlated with PRGO. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ORGO jumps, then PRGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORGO
1D Price
Change %
ORGO100%
+2.85%
PRGO - ORGO
47%
Loosely correlated
+1.85%
ANIP - ORGO
44%
Loosely correlated
+1.40%
AMRX - ORGO
32%
Poorly correlated
+1.68%
ACET - ORGO
29%
Poorly correlated
+2.34%
AMPH - ORGO
27%
Poorly correlated
+1.83%
More

PRGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRGO has been loosely correlated with ORGO. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if PRGO jumps, then ORGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRGO
1D Price
Change %
PRGO100%
+1.85%
ORGO - PRGO
47%
Loosely correlated
+2.85%
ANIP - PRGO
39%
Loosely correlated
+1.40%
AMRX - PRGO
32%
Poorly correlated
+1.68%
VTRS - PRGO
31%
Poorly correlated
+1.59%
EOLS - PRGO
27%
Poorly correlated
+0.77%
More